Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB1 | Q9H4B7 | 6/20 | 0.60 |
| ▸ | TUBB4A | P04350 | 5/20 | 0.60 |
| ▸ | TUBB | P07437 | 5/20 | 0.60 |
| ▸ | TUBA3C | P0DPH7 | 5/20 | 0.60 |
| ▸ | TUBA1B | P68363 | 5/20 | 0.60 |
| ▸ | TUBA4A | P68366 | 5/20 | 0.60 |
| ▸ | TUBB4B | P68371 | 5/20 | 0.60 |
| ▸ | TUBB3 | Q13509 | 5/20 | 0.60 |
| ▸ | TUBB2A | Q13885 | 5/20 | 0.60 |
| ▸ | TUBB8 | Q3ZCM7 | 5/20 | 0.60 |
| ▸ | TUBA3E | Q6PEY2 | 5/20 | 0.60 |
| ▸ | TUBA1A | Q71U36 | 5/20 | 0.60 |
| ▸ | TUBA1C | Q9BQE3 | 5/20 | 0.60 |
| ▸ | TUBB6 | Q9BUF5 | 5/20 | 0.60 |
| ▸ | TUBB2B | Q9BVA1 | 5/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | NQO1 | P15559 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2028815 | 1.00 | TUBB1 (0.60) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL4652668 | 0.91 | HTT (0.53) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL4652665 | 0.91 | HTT (0.53) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL14723015 | 0.90 | POLB (0.54) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL14723014 | 0.90 | POLB (0.54) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL4651506 | 0.90 | TUBB4A (0.54) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL4651503 | 0.90 | TUBB4A (0.54) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL15862412 | 0.90 | TUBB4A (0.54) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL14734631 | 0.90 | TUBB4A (0.54) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL4651509 | 0.87 | POLB (0.58) | TUBB1TUBB4ATUBBTUBA3CTUBA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7959990-B2 | Adjustment of liquid crystals; oligomers, dendrimers, or polymer in solution is applied to support; crosslinking by radiation or polarized light | ROLIC AG (CH) | 2011-06-14 | — | — | US | disclosed |
| EP-1928979-B1 | FUNCTIONALIZED PHOTOREACTIVE COMPOUNDS | ROLIC AG (CH) | 2009-03-04 | — | — | EP | disclosed |
| US-20080274304-A1 | Functionalized Photoreactive Compounds | ROLIC AG (CH) | 2008-11-06 | — | — | US | disclosed |
| EP-1975687-A1 | Method of uniform and defect free liquid crystal aligning layers | Rolic AG (CH) | 2008-10-01 | — | — | EP | disclosed |
| EP-1928979-A1 | FUNCTIONALIZED PHOTOREACTIVE COMPOUNDS | Rolic AG (CH) | 2008-06-11 | — | — | EP | disclosed |
| WO-2007033506-A1 | FUNCTIONALIZED PHOTOREACTIVE COMPOUNDS | ROLIC AG (CH) | 2007-03-29 | — | — | WO | disclosed |
| EP-1764405-A1 | Functionalized photoreactive compounds | Rolic AG (CH) | 2007-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080274304-A1 | Functionalized Photoreactive Compounds | PCNA, PIN1, MAP1LC3C | TUBB1 335/4885TUBB4A 124/4885TUBB 370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.